CSIMarket


Cerevel Therapeutics Holdings Inc   (CERE)
Other Ticker:  
 

Cerevel Therapeutics Holdings Inc

CERE's Fundamental analysis








Cerevel Therapeutics Holdings Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Cerevel Therapeutics Holdings Inc net loss deacreased by in III. Quarter 2023 year on year, Cerevel Therapeutics Holdings Inc net loss increased by -3.58 % in III. Quarter 2023 year on year,

More on CERE's Growth


Cerevel Therapeutics Holdings Inc
realized net loss in trailing twelve months.

Cerevel Therapeutics Holdings Inc realized cash outflow of $ -0.59per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.


More on CERE's Valuation
 
 Total Debt (Millions $) 337
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.73

Cerevel Therapeutics Holdings Inc
realized net loss in trailing twelve months.

Cerevel Therapeutics Holdings Inc realized cash outflow of $ -0.59per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.

Cerevel Therapeutics Holdings Inc Price to Book Ratio is at 23.93 lower than Indusry Avg. of 76.48. and higher than S&P 500 Avg. of 0.01

More on CERE's Valuation

  Market Capitalization (Millions $) 6,531
  Shares Outstanding (Millions) 158
  Employees 44
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -393
  Cash Flow (TTM) (Millions $) -93
  Capital Exp. (TTM) (Millions $) -3
  Total Debt (Millions $) 337
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 1.73

  Market Capitalization (Millions $) 6,531
  Shares Outstanding (Millions) 158
  Employees 44
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -393
  Cash Flow (TTM) (Millions $) -93
  Capital Exp. (TTM) (Millions $) -3





  Ratio
   Capital Ratio (MRQ) 8.72
  Total Debt to Equity (MRQ) 1.23
  Tangible Leverage Ratio (MRQ) 2.01
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com